BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/29/2026 8:41:31 AM | Browse: 2 | Download: 10
 |
Received |
|
2026-01-09 03:40 |
|
Peer-Review Started |
|
2026-01-09 03:40 |
|
First Decision by Editorial Office Director |
|
2026-01-19 08:50 |
|
Return for Revision |
|
2026-01-19 08:50 |
|
Revised |
|
2026-01-27 20:39 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-02 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-02 07:26 |
|
Articles in Press |
|
2026-03-02 07:26 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-29 09:33 |
|
Publish the Manuscript Online |
|
2026-05-29 08:41 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Minireviews |
| Article Title |
Glucagon-like peptide-1 agonists usage to widen the living donor pool for liver transplantation: A novel metabolic strategy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Amr Alnagar, Muhammad U Khan, Muhammad S Ahmad, Mahmoud Mersal, Mohamed Ayyad, Rana Hassan and Mohamed Saleem Noormohamed |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amr Alnagar, PhD, Department of General Surgery, University Hospitals of Birmingham, 6 Chamberlain Road, Birmingham B9 5SS, United Kingdom. amr.alnagar@nhs.net |
| Key Words |
Liver transplantation; Obesity; Graft pool; Steatosis; Donor |
| Core Tip |
The use of glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonists for weight loss is expanding, particularly as bridging therapies for living donors in liver transplantation. High body mass index donors are often declined due to safety concerns, but weight reduction can improve surgical outcomes and reduce morbidity and mortality. There is growing clinical evidence supporting these agents to minimize perioperative complications. However, they should be used cautiously due to potential side effects like delayed gastric emptying and aspiration risks. |
| Publish Date |
2026-05-29 08:41 |
| Citation |
Alnagar A, Khan MU, Ahmad MS, Mersal M, Ayyad M, Hassan R, Noormohamed MS. Glucagon-like peptide-1 agonists usage to widen the living donor pool for liver transplantation: A novel metabolic strategy. World J Transplant 2026; 16(2): 118702 |
| URL |
https://www.wjgnet.com/2220-3230/full/v16/i2/118702.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v16.i2.118702 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
